November 22, 2024 FDA Approves Bimzelx for Hidradenitis Suppurativa Bimzelx is the first hidradenitis suppurativa treatment selectively targeting both interleukin-17A and interleukin-17F. Conexiant
November 18, 2024 Hidden Heart Risks of Psoriasis Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death. Conexiant
November 18, 2024 Renowned Dermatologist Goldsmith Dies at 86 "No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine. Conexiant